  Somatic mutations in cancer cells affect various genomic elements disrupting
important cell functions. In particular, mutations in DNA binding sites
recognized by transcription factors can alter regulator binding affinities and
expression of target genes. A number of promoter mutations have been linked
with an increased risk of cancer, mutations in binding sites of selected
transcription factors have been found under positive selection. However,
negative selection of mutations in coding regions is elusive and significance
of negative selection in non-coding regions remains controversial.
  Here we present analysis of transcription factors with binding sites
co-localized with non-coding variants. To avoid statistical bias we account for
mutation signatures of different cancer types. For many transcription factors,
including multiple members of FOX, HOX, and NR families, we show that human
cancers accumulate fewer mutations than expected by chance that increase or
decrease affinity of binding motifs. Such conservation of motifs is even more
exhibited in DNase accessible regions.
  Our data demonstrate negative selection against binding sites alterations and
suggest that this selection pressure protects cancer cells from rewiring of
regulatory circuits. Further analysis of transcription factors and the
respective conserved binding motifs can reveal cell regulatory pathways crucial
for the survivability of various human cancers.
